Neoadjuvant toripalimab plus CapeOX in locally advanced Epstein-Barr virus-associated gastric or gastroesophageal junction adenocarcinoma: a phase Ⅱ trial

Journal:

Nature Communications

Published:

2026-04-23

DOI:

10.1038/s41467-026-72059-7

Affiliations:

8

Authors:

20

Go to article

Institutions	Authors	Share
Nanfang Hospital, China	14.500000 14.500000	0.73
Beijing Tsinghua Chang Gung Hospital, Tsinghua, China	1.500000	0.08
Sun Yat-sen University Cancer Center (SYSUCC), SYSU, China	1.000000	0.05
State Key Laboratory of Oncology in South China, SYSUCC, China	1.000000	0.05
Fujian Provincial Hospital, China	1.000000	0.05
3D Medicines Inc., China	1.000000	0.05

Interested in Oncology and Carcinogenesis?